Hosted on MSN11mon
Research team develops novel PTPN2/N1 inhibitor for cancer immunotherapy using generative AIOne such avenue is through the protein tyrosine phosphatase non-receptor type 2 (PTPN2) and its close superfamily member, PTPN1, identified in previous research as crucial modulators involved in ...
Nerio Therapeutics Inc. has synthesized proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase-binding moiety coupled to a tyrosine-protein phosphatase non-receptor type 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback